Related Funds
Fund Name | Location |
350 Capital | Canada, Ontario, Toronto |
ARCH Healthcare Fund | - |
Atlas Pacific Capital | California, San Jose, United States |
Avendus Capital | New York, New York, United States |
Blue Cloud Ventures | New York, New York, United States |
Ensys Capital | Austin, Texas, United States |
Gabriel Capital Management | New York, New York, United States |
Heyu Ziben | China, Guangdong, Shenzhen |
HLM Management Company | Boston, Massachusetts, United States |
HomeAway | Austin, Texas, United States |
HP Ventures Group | Chicago, Illinois, United States |
i4g Investment | Austria, Vienna |
ITX Corporation | New York, Pittsford, United States |
Jadebird Capital | Beijing, Beijing, China |
Premier Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
Southeast Minnesota Capital Fund | Minnesota, Rochester, United States |
ZB.COM | Switzerland, Zürich, Zurich |
Zhejiang Xunguang Touzi Guanli Youxian Gongsi | China, Zhejiang, Zhoushan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Yuanxin Satellite | $1B | 01 Feb 2024 | Shanghai, Shanghai, China | ||
CloudMinds | $154M | 06 Jul 2023 | San Jose, California, United States | ||
Ucello Therapeutics | $23M | 02 Jun 2023 | Chengdu, Sichuan, China | ||
Yi Mufeng | $30M | 30 Dec 2022 | Shanghai, Shanghai, China | ||
NeuroXess | 28 Dec 2022 | Huangpu, Shanghai, China | |||
kuorangene | 20 Jul 2022 | Shanghai, Shanghai, China | |||
SiEngine technology | $154M | 19 Jul 2022 | Shanghai, Shanghai, China | ||
Iluvatar CoreX | $154M | 13 Jul 2022 | Xuanwu District, Jiangsu, China | ||
MetaX | $154M | 05 Jul 2022 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Yuanxin Satellite | $1B | 01 Feb 2024 | Shanghai, Shanghai, China | ||
CloudMinds | $154M | 06 Jul 2023 | San Jose, California, United States | ||
Ucello Therapeutics | $23M | 02 Jun 2023 | Chengdu, Sichuan, China | ||
Yi Mufeng | $30M | 30 Dec 2022 | Shanghai, Shanghai, China | ||
NeuroXess | 28 Dec 2022 | Huangpu, Shanghai, China | |||
kuorangene | 20 Jul 2022 | Shanghai, Shanghai, China | |||
SiEngine technology | $154M | 19 Jul 2022 | Shanghai, Shanghai, China | ||
Iluvatar CoreX | $154M | 13 Jul 2022 | Xuanwu District, Jiangsu, China | ||
MetaX | $154M | 05 Jul 2022 | Shanghai, China |